Top

Indian Journal of Otolaryngology and Head & Neck Surgery

Published in:

26-04-2023 | Lymphoma | Clinical Report

Tracheal Inflammatory Myofibroblastic Tumour ALK+ as Cause of Dyspnea in a 10 Years Old Child

Authors: Andrés González Fernández, Nerea Zubicaray Ayestarán, Sheila Huerga Miguélez

Published in: Indian Journal of Otolaryngology and Head & Neck Surgery | Issue 3/2023

Abstract

Inflammatory myofibroblastic tumours are rare lesions that could occur in airways. We report a 10 years old male who complains about dyspnea after physical exercise. Making CT and RMI images and a biopsy, we make an accurate diagnosis of an inflammatory myofibroblastic tumour ALK+. After treatment with a subtotal resection and crizotinib as adjuvant, we achieve a complete remission.

Available only for authorised users

Kumar N, Saravanamuthu T, Srinivasan A, Raman T, Scott JX Pediatric Inflammatory Myofibroblastic Tumors of the Airway: two case reports with varying clinical presentation.Iran J Otorhinolaryngol. 2018 May; 30(98):171–176. PMID: 29876333; PMCID: PMC5985620.

Lisi R, Abate G, D’Urso P, Martinetti MT, Siniscalchi B, Marampon F, Bulzonetti N, Tombolini V (2019 Dec) Successful role of adjuvant radiotherapy in a rare case of tracheal inflammatory myofibroblastic tumor: a case report. Tumori 105(6):NP1–NP3. https://doi.org/10.1177/0300891619838333Epub 2019 Mar 22. PMID: 30900517

Pecoraro Y, Diso D, Anile M, Russo E, Patella M, Venuta F (2014 Dec) Primary inflammatory myofibroblastic tumor of the trachea. Respirol Case Rep 2(4):147–149. https://doi.org/10.1002/rcr2.81Epub 2014 Oct 15. PMID: 25530866; PMCID: PMC4263498

Liu W, Duan Q, Gong L, Yang Y, Huang Z, Guo H, Niu X (2021) Feb;39(1):278–282 A novel LRRFIP1-ALK fusion in inflammatory myofibroblastic tumor of hip and response to crizotinib. Invest New Drugs. doi: 10.1007/s10637-020-00984-5. Epub 2020 Sep 11. PMID: 32915420

Elktaibi A, Benzerdjeb N, Ameur F, Daveau C, Tantot J, Costes Martineau VA, Novel (2020 Jun) ALK-THBS1 Fusion in a laryngeal inflammatory myofibroblastic tumour: a Case Report and Literature Review. Head Neck Pathol 14(2):454–458. https://doi.org/10.1007/s12105-019-01061-xEpub 2019 Jul 31. PMID: 31368077; PMCID: PMC7235104

Theilen TM, Soerensen J, Bochennek K, Becker M, Schwabe D, Rolle U, Klingebiel T, Lehrnbecher T Crizotinib in ALK⁺ inflammatory myofibroblastic tumors-current experience and future perspectives.Pediatr Blood Cancer. 2018Apr; 65(4). doi: https://doi.org/10.1002/pbc.26920. Epub 2017 Dec 29. PMID: 29286567.

Kieu MQ, Thottam PJ, DaCosta V, Gonzalez-Krellwitz L, Poulik JM, Madgy DN (2014) Nov;28(6):841.e1-4 Treatment of inflammatory myofibroblastic tumor of the subglottis with KTP laser: a case report. J Voice. doi: https://doi.org/10.1016/j.jvoice.2014.03.016. Epub 2014 Jun 24. PMID: 24972538

Butrynski JE, D’Adamo DR, Hornick JL, Dal Cin P, Antonescu CR, Jhanwar SC, Ladanyi M, Capelletti M, Rodig SJ, Ramaiya N, Kwak EL, Clark JW, Wilner KD, Christensen JG, Jänne PA, Maki RG, Demetri GD, Shapiro GI (2010) Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor. N Engl J Med. Oct 28;363(18):1727-33. doi: https://doi.org/10.1056/NEJMoa1007056. PMID: 20979472; PMCID: PMC3014292

Casanova M, Brennan B, Alaggio R, Kelsey A, Orbach D, van Noesel MM, Corradini N, Minard-Colin V, Zanetti I, Bisogno G, Gallego S, Merks JHM, De Salvo GL, Ferrari A (2020 Mar) Inflammatory myofibroblastic tumor: the experience of the european pediatric soft tissue Sarcoma Study Group (EpSSG). Eur J Cancer 127:123–129 Epub 2020 Jan 30. PMID: 32007712

10.

Coffin CM, Hornick JL, Fletcher CD Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol. 2007 Apr;31(4):509 – 20. doi: https://doi.org/10.1097/01.pas.0000213393.57322.c7. PMID: 17414097

11.

Gilani SM, Kowalski PJ (2014 Mar) Inflammatory myofibroblastic tumour: a rare entity with wide differential diagnosis. Pathologica 106(1):1–6 PMID: 24897773

Title: Tracheal Inflammatory Myofibroblastic Tumour ALK+ as Cause of Dyspnea in a 10 Years Old Child
Authors: Andrés González Fernández
Nerea Zubicaray Ayestarán
Sheila Huerga Miguélez
Publication date: 26-04-2023
Publisher: Springer India
Keywords: Lymphoma
Dyspnea
Dyspnea
Crizotinib
Cytostatic Therapy
Published in: Indian Journal of Otolaryngology and Head & Neck Surgery / Issue 3/2023
Print ISSN: 2231-3796
Electronic ISSN: 0973-7707
DOI: https://doi.org/10.1007/s12070-023-03775-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Tracheal Inflammatory Myofibroblastic Tumour ALK+ as Cause of Dyspnea in a 10 Years Old Child

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2023

Repeated Surgery in a Case of Epithelial-Myoepithelial Carcinoma of the Parotid Gland that was Difficult to Distinguish from Pleomorphic Adenoma

Solitary Extraosseous Plasmacytoma of Submandibular Gland – Report of a Rare Case

Complete Second Branchial Fistula: A Rare Entity

Hearing Outcomes in the Audiology Department of a Children Hospital

Parental Perception of Self- Efficacy for the Rehabilitation of Children with Cochlear Implantation

Hemangioma – A Rare Cause of Laryngeal Growth in an Adult and its Management with Sclerotherapy and Laser Surgery: A Case Report